Next Article in Journal
Downregulation of P300/CBP-Associated Factor Protects from Vascular Aging via Nrf2 Signal Pathway Activation
Next Article in Special Issue
Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia
Previous Article in Journal
Regulation of Molecular Targets in Osteosarcoma Treatment
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2022, 23(20), 12582; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms232012582
Action Date Notes Link
article xml file uploaded 20 October 2022 10:11 CEST Original file -
article xml uploaded. 20 October 2022 10:11 CEST Update -
article pdf uploaded. 20 October 2022 10:11 CEST Version of Record https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/23/20/12582/pdf-vor
article html file updated 20 October 2022 10:12 CEST Original file -
article xml file uploaded 26 October 2022 08:54 CEST Update -
article xml uploaded. 26 October 2022 08:54 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/23/20/12582/xml
article pdf uploaded. 26 October 2022 08:54 CEST Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/23/20/12582/pdf
article html file updated 26 October 2022 08:56 CEST Update -
article html file updated 28 February 2023 19:00 CET Update -
article html file updated 1 March 2023 23:06 CET Update https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/23/20/12582/html
Back to TopTop